Sevelamer Hydrochloride Tablet, Film Coated
Product Images NDC 72603-148

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sevelamer Hydrochloride (NDC 72603-148). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

800mgbottle Label (800mgbottle Label)

800mgbottle Label (800mgbottle Label)
This is a description of Sevelamer Hydrochloride Tablets, which come in a package of 180 film-coated tablets containing 800 mg of sevelamer hydrochloride per tablet. Dosage instructions are available in the package insert and the tablets should be stored at room temperature in a tight container protected from moisture. The tablets are manufactured by Glenmark Pharmaceuticals Limited in India for Northstar Rx LLC in Memphis, TN.*
FDA Label Image

Chemical-structure (Chemical Structure)

FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
This appears to be a chart showing the percentage of patients with a reduction in serum phosphorus levels from baseline after treatment with Sevelamer hydrochloride compared to an active control. The chart contains values and labels for reductions greater than a certain amount ("X") on the x-axis and percentages on the y-axis. It also includes labels for different types of reductions on the bottom and a legend for different treatments on the right.*
FDA Label Image

Figure-3 (Figure 3)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.